Suppr超能文献

健康与疾病中的微生物-肠道相互作用。黏膜免疫反应。

Microbial-gut interactions in health and disease. Mucosal immune responses.

作者信息

Acheson David W K, Luccioli Stefano

机构信息

Food and Drug Administration, Center for Food Safety and Applied Nutrition, DHSS/FDA/CFSAN, 5100 Paint Branch Parkway, Mail Code HFS 6, Room 2B-003, College Park, MD 20740-3835, USA.

出版信息

Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):387-404. doi: 10.1016/j.bpg.2003.11.002.

Abstract

The host gastrointestinal tract is exposed to countless numbers of foreign antigens and has embedded a unique and complex network of immunological and non-immunological mechanisms, often termed the gastrointestinal 'mucosal barrier', to protect the host from potentially harmful pathogens while at the same time 'tolerating' other resident microbes to allow absorption and utilization of nutrients. Of the many important roles of this barrier, it is the distinct responsibility of the mucosal immune system to sample and discriminate between harmful and beneficial antigens and to prevent entry of food-borne pathogens through the gastrointestinal (GI) tract. This system comprises an immunological network termed the gut-associated lymphoid tissue (GALT) that consists of unique arrangements of B cells, T cells and phagocytes which sample luminal antigens through specialized epithelia termed the follicle associated epithelia (FAE) and orchestrate co-ordinated molecular responses between immune cells and other components of the mucosal barrier. Certain pathogens have developed ways to bypass and/or withstand defence by the mucosal immune system to establish disease in the host. Some 'opportunistic' pathogens (such as Clostridium difficile) take advantage of host or other factors (diet, stress, antibiotic use) which may alter or weaken the response of the immune system. Other pathogens have developed mechanisms for invading gastrointestinal epithelium and evading phagocytosis/destruction by immune system defences. Once cellular invasion occurs, host responses are activated to limit local mucosal damage and repel the foreign influence. Some pathogens (Shigella spp, parasites and viruses) primarily establish localized disease while others (Salmonella, Yersinia, Listeria) use the lymphatic system to enter organs or the bloodstream and cause more systemic illness. In some cases, pathogens (Helicobacter pylori and Salmonella typhi) colonize the GI tract or associated lymphoid structures for extended periods of time and these persistent pathogens may also be potential triggers for other chronic or inflammatory diseases, including inflammatory bowel disease and malignancies. The ability of certain pathogens to avoid or withstand the host's immune assault and/or utilize these host responses to their own advantage (i.e. enhance further colonization) will dictate the pathogen's success in promoting illness and furthering its own survival.

摘要

宿主胃肠道会接触到无数的外来抗原,并构建了一个独特而复杂的免疫和非免疫机制网络,通常称为胃肠道“黏膜屏障”,以保护宿主免受潜在有害病原体的侵害,同时“容忍”其他常驻微生物,以便吸收和利用营养物质。在这个屏障的众多重要作用中,黏膜免疫系统的独特职责是对有害和有益抗原进行采样和区分,并防止食源性病原体通过胃肠道进入。这个系统由一个称为肠道相关淋巴组织(GALT)的免疫网络组成,它由B细胞、T细胞和吞噬细胞的独特排列构成,这些细胞通过称为滤泡相关上皮(FAE)的特殊上皮对腔内抗原进行采样,并协调免疫细胞与黏膜屏障其他成分之间的分子反应。某些病原体已经发展出绕过和/或抵御黏膜免疫系统防御的方法,从而在宿主体内引发疾病。一些“机会性”病原体(如艰难梭菌)利用宿主或其他因素(饮食、压力、抗生素使用),这些因素可能会改变或削弱免疫系统的反应。其他病原体则发展出侵入胃肠道上皮并逃避免疫系统防御的吞噬/破坏的机制。一旦发生细胞入侵,宿主反应就会被激活,以限制局部黏膜损伤并抵御外来影响。一些病原体(志贺氏菌属、寄生虫和病毒)主要引发局部疾病,而其他病原体(沙门氏菌、耶尔森氏菌、李斯特菌)则利用淋巴系统进入器官或血液,导致更全身性的疾病。在某些情况下,病原体(幽门螺杆菌和伤寒沙门氏菌)会长时间定植在胃肠道或相关淋巴结构中,这些持续性病原体也可能是其他慢性或炎症性疾病(包括炎症性肠病和恶性肿瘤)的潜在触发因素。某些病原体避免或抵御宿主免疫攻击和/或利用这些宿主反应为自身谋利(即增强进一步定植)的能力,将决定病原体在引发疾病和促进自身生存方面的成功与否。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验